Silence Therapeutics
(OTCPK:SLNCF)
$8.00
0[0.00%]
Last update: 12:20PM Get Real Time Here

Silence Therapeutics Stock (OTC:SLNCF), Quotes and News Summary

Silence Therapeutics Stock (OTC: SLNCF) stock price, news, charts, stock research, profile.

Open-
Close-
Volume / Avg.0 / 1.285K
Day Range- - -
52 Wk Range0.600 - 10.900
Market Cap$1.119B
P/E Ratio-
Dividend Yield-
ExchangeOTC
RSI
0
Short Interest-
Days to Cover999.99
-%

Financials

Quarterly
Annual
Name
Revenue
Change
Gross
Change
EBITDA
Change
EBIT
Change
Earnings
Change
About
Sector
Healthcare
Industry
N/A
Silence Therapeutics PLC is a biotechnology company focused on discovering and developing novel mole...
Show More

Compare

EPS worse than industry
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
SLNCF

FAQ

Q

How do I buy Silence Therapeutics (SLNCF) stock?

A

You can purchase shares of Silence Therapeutics (OTCPK: SLNCF) through any online brokerage.

View our list of the best stock brokerages.

Q

Who are Silence Therapeutics's (SLNCF) competitors?

A

There are no as such competitors for Silence Therapeutics.

Q

What is the target price for Silence Therapeutics (SLNCF) stock?

A

There is no analysis for Silence Therapeutics.

Q

Current Stock Price for Silence Therapeutics (SLNCF)?

A

The stock price for Silence Therapeutics (OTCPK: SLNCF) is $8 last updated April 18, 2024 at 12:20 PM EDT.

Q

Does Silence Therapeutics (SLNCF) pay a dividend?

A

There are no upcoming dividends for Silence Therapeutics.

Q

When is Silence Therapeutics (OTCPK:SLNCF) reporting earnings?

A

Silence Therapeutics does not have any upcoming earnings scheduled.

Q

Is Silence Therapeutics (SLNCF) going to split?

A

There is no upcoming split for Silence Therapeutics.

Q

What sector and industry does Silence Therapeutics (SLNCF) operate in?

A

Silence Therapeutics is in the Healthcare sector and Biotechnology industry. They are listed on the OTCPK.